← Browse by Condition
Medical Condition

relapsed refractory b cell malignancies

Total Trials
3
Recruiting Now
3
Trial Phases
EARLY_Phase 1, Phase 1
NCT07240974 EARLY_Phase 1
Recruiting

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Enrollment
6 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
View Trial →
NCT07002112 Phase 1
Recruiting

The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies

Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT07345728
Recruiting

Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies

Enrollment
28 pts
Location
China
Sponsor
Donghua Zhang
View Trial →